Clinical trials: Nanopore Sequencing
Whole Genome Sequencing, Genetic Disease
N-Care Project: Enhancing Asian-Pacific Collaboration
Through Asian-Pacific multinational collaboration, we aim to utilize third-generation genome sequencing to rapidly diagnose genetic diseases in critically ill infants and young children, achieving the goal of early diagnosis for…
- Conditions
- Whole Genome Sequencing, Genetic Disease, Critical Care, Intensive Care, Nanopore Sequencing
- Trial name
- N-Care project (NCT06821386)
- Testing
- Genetic study with nanopore sequencing
- Where
- Taiwan
- Volunteers
- 70 people
- Sponsor
- National Taiwan University Hospital
Cervical Cancers, HPV Testing
Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis
Cervical cancer is a significant health threat to women, with over 500,000 new cases and approximately 342,000 deaths worldwide annually, and about 107,000 new cases in China with 51,000 fatalities.
- Conditions
- Cervical Cancers, HPV Testing, Nanopore Sequencing, HPV Integration Site Detection
- Trial name
- NCT06644677
- Testing
- HPV integration
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Peking Union Medical College Hospital